A Surgeon's Experience of GreenLight TM Laser Therapy for Benign Prostatic Hyperplasia
An interview with Mr Gordon Muir (Consultant Urological Surgeon, King's College NHS Foundation Trust) following the ‘GreenLight™ Laser System for Day-Case Surgery’ symposium at the 33rd World Congress of Endourology and SWL 2015 in London, UK.
Mr Muir, from Kings College London, talks to us about his experiences of using Greenlight over a number of years, and how it can be utilised most effectively. Additionally, he discusses the importance of improving the quality of life for different types of patients following the treatment.
Видео A Surgeon's Experience of GreenLight TM Laser Therapy for Benign Prostatic Hyperplasia канала EMJ
Mr Muir, from Kings College London, talks to us about his experiences of using Greenlight over a number of years, and how it can be utilised most effectively. Additionally, he discusses the importance of improving the quality of life for different types of patients following the treatment.
Видео A Surgeon's Experience of GreenLight TM Laser Therapy for Benign Prostatic Hyperplasia канала EMJ
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Detailed timelines of cancer development](https://i.ytimg.com/vi/rUQyZ9QU2Vk/default.jpg)
![Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 1)](https://i.ytimg.com/vi/NvZpd6PyqdM/default.jpg)
![Introducing the Oncotype DX® Breast Cancer Assay and its impact in clinical practice](https://i.ytimg.com/vi/2ucrjrFrihU/default.jpg)
![Immunotherapy: Targeting tumour heterogeneity](https://i.ytimg.com/vi/xJWMwpfRV4k/default.jpg)
![Prof. Wim Van Aalderen – Introducing WheezeScan: a new tool to help parents confirm a wheeze](https://i.ytimg.com/vi/H-0SLgL_1Dw/default.jpg)
![Melasma & Hyperpigmentation Key Considerations + Evidence to Support Novel Agents – Prof. Berardesca](https://i.ytimg.com/vi/9tbkkqd9ZF4/default.jpg)
![Dr Abraham Ari Hakimi discusses sarcomatoid renal cell carcinoma (RCC)](https://i.ytimg.com/vi/XlEBnlWrPJQ/default.jpg)
![ManVan: Mobile cancer support for prostate, testicular and penile cancer](https://i.ytimg.com/vi/LvAXABHzI8g/default.jpg)
![An Interview with Rodrigo Gribble from AstraZeneca](https://i.ytimg.com/vi/AAQi_0B1W4w/default.jpg)
![New Issue of Gold Teaser!](https://i.ytimg.com/vi/E1Y5ujiNepQ/default.jpg)
![ESHRE 2019 – Interview – Prof Claire Roberts](https://i.ytimg.com/vi/PZ6SnCbA3Z0/default.jpg)
![Targeting BCL-2 for treating oestrogen-positive breast cancer](https://i.ytimg.com/vi/j-rDyqlklL4/default.jpg)
![Phase 3 CheckMate 067 trial of nivolumab in previously untreated advanced melanoma](https://i.ytimg.com/vi/5--6RQvNzqI/default.jpg)
![LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated lung cancer in first-line](https://i.ytimg.com/vi/FCPYx0QHLvg/default.jpg)
![EULAR 2022: Can ultrasound make the invisible visible in PsA](https://i.ytimg.com/vi/ECd6V8YPnvU/default.jpg)
![TDM and T2T - Perfect Partners](https://i.ytimg.com/vi/sPwsqVXftSs/default.jpg)
![2015 NCRI Cancer Conference: Francis Crick Institute scientists](https://i.ytimg.com/vi/vxMUvslOOKc/default.jpg)
![2015 NCRI Cancer Conference: Featured sessions](https://i.ytimg.com/vi/2jw786ylRkg/default.jpg)
![EADV 2018 - Congress Highlights](https://i.ytimg.com/vi/qt5aqT1A-5Y/default.jpg)
![Overactive Bladder - Part Two: Evaluation and Management](https://i.ytimg.com/vi/iW-_Sy8hqNE/default.jpg)
![An Interview with Kasper Jerlang from LEO Pharma](https://i.ytimg.com/vi/8wf_n1lDAZg/default.jpg)